Clinical Trial

Role of Urine PH in Shock Wave Lithotripsy Outcomes in Renal Stone Disease

Study acronym: PHESWL
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
urolethiasis (kidney stones) is common globally, with recurrence in 50% of patients. * Shock Wave Lithotripsy (SWL) is a minimally invasive treatment for stones \< 2 cm. * Hypothesis: Urine pH might influence SWL success and could be manipulated pre-procedure. Aim of the work is to evaluate the role urine pH on the outcomes of shock wave lithotripsy in renal stones. patients and methods The study will be conducted over 146 patients( with single renal stone \< 2 cm) in Urology department of Banha university Hopitals from Dec 2025 till Dec 2026. Exclusions: patients on pH altering drugs, multiple stones,stents. Procedure: SWL Siemens Lithoscope up to 3 sessions per patient. Data collected : Age, BMI, urine pH, specific gravity(SG), stone size, location, Hounsfield unit(HU), skin to stone distance (SSD). Analysis Chi-square\& t-test; significance at p\<0.05. Results Will be tabulated and statistically analyzed
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-14.
Trial Details
NCT Number NCT07711028
Lead Sponsor Benha University
Conditions Shockwave Therapy
Enrollment 146 participants
Start Date 2026-01-20
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-20